Products

Contact Us

Name: Mr.Alex

Tel: 86-29-8918-1410

86-187-0910-6130

Email: sales@fengzusw.com

Skype: fengzusw

WhatsApp: +86-135-7241-4292

GMP Standard Rivaroxaban Powder, USP EP Standard Rivaroxaban Price

GMP Standard Rivaroxaban Powder, USP EP Standard Rivaroxaban Price

Rivaroxaban can be used to prevent strokes in those with atrial fibrillation.FZBIOTECH,as a manufacturer of monomer, has been devoting to supplying the best quality Rivaroxaban to all over the world with best price. For long term cooperation, free sample is available.Chat Now
Description

Basic information of Rivaroxaban

Product Name:Rivaroxaban

CAS Number:366789-02-8

Molecular Formula:C19H18ClN3O5S

Molecular Weight:435.88

Appearance:White or milk white crystalline porde

Assay:99%

Structural Formula

Rivaroxaban.gif

Introduction of Rivaroxaban 

Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from thegut and maximum inhibition of factor Xa occurs four hours after a dose.The effects lasts 8 to 12 hour,but factor Xa activity does not return to normal within 24 hours so once daily dosing is possible.There is currently no specific way to reverse the anticoagulant effect of rivaroxaban in the event ofa major bleeding event, unlike warfarin.


Benefits of Rivaroxaban  

Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valvedisease, an at least one additional risk factor for stroke (congestive heart failure, hypertension,  age, diabetes, and prior stroke)

Rivaroxaban can also be used to prevent the formation of blood clots in the veins (deep venous thrombosis) in adults who have had an operation to replace a hip or knee and for treatment and prevention of acute deep venous thrombosis in adults.It can not be used for prevention of venous thrombosis in hospitalized medically ill patients.

Rivaraban is not indicated for prosthetic heart valves or for mitral stenosis.

Rivaroxaban is not indicated as an addon treatment for dual antiplatelet therapy in the secondary prevention of coronary incidents (double and triple therapy). In Europe, however, a 2.mg twicedaily dose was approved by the European Commission after a recommendation by the European Medicines Agency (EMA) for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers coadministered with acetylsalicylic acid (ASA) alone or with ASA plus clopidogrel or ticlopidine.


Shipping and Package

Rivaroxaban.jpg

Rivaroxaban.jpg


Company

Rivaroxaban.jpg

Rivaroxaban.jpg


Xi'an Fengzu Biological Technology Co.,Ltd is one of the professional China gmp standard rivaroxaban,usp rivaroxaban,ep rivaroxabanpowder manufacturers, for all you needs of best, price, organic, 100% pure, nature, and GMP factory gmp standard rivaroxaban,usp rivaroxaban,ep rivaroxabanpowder, please feel free to contact us. And welcome to wholesale bulk and high quantity gmp standard rivaroxaban,usp rivaroxaban,ep rivaroxabanpowder from us.

Related Products
Feedback
Xi'an Fengzu Biological Technology Co.,Ltd
Manufacturer Add: Industrial Park in Wugong County, Xianyang City,Shaanxi Province, China.
Office Add: 21F, Tangfengguoji,No.18 Fenghuinanlu, Xi'an City, Shaanxi Province, China.
Office Tel: 86-029-89561932/86-135-7248-9476             Office Fax: 86-029-8918-9705
Email: sales@fengzusw.com                                            Skype: fengzusw